Search Results of Projects/Service Agreements

Title	Reference	Short name	Effective start date	Status
UCIBIO - UIDB/04378 Financiamento Base (2025-2029)	UIDB/04378 (2025-2029)	UCIBIO - UIDB/04378/2025	2025-01-01	In Progress
Enhancement of Agro Food Chain Byproducts through Innovative and Sustainable Methods	2024-1-RO01-KA220-HED-000246776	eAfoBy	2024-12-16	In Progress
Beating Hard-To-Treat Cancer With A First-In-Class Inhibitor Of Dna Damage Response	BtoBEAT-TNBC	BtoBEAT-TNBC	2024-09-01	In Progress
Reincorporación de residuos de las industrias vinícola y hortofrutícola a la cadena alimentaria a través de la elaboración de alimentos funcionales.	SBPLY/23/180225/000011	SBPLY/23/180225/000011	2024-05-01	In Progress
Low-cost rapid diagnostics & typing for clinical microbiology using FTIR	INV-060596	INV-060596	2024-02-16	In Progress
Development and Validation of Fourier transform infrared (FT-IR) spectroscopy for rapid typing of multidrug resistant Escherichia coli and infection control	Study Group Research Grant Agreement 2024	Study Group Research Grant Agreement 2024	2024-02-01	In Progress
UCIBIO \| UIDP/04378/2020	UCIBIO \| UIDP/04378/2020	UCIBIO \| UIDP/04378/2020	2024-01-01	Completed
BtoBEAT-TNBC: ESTABLISHING LETHAL COMBINATIONS WITH A FIRST-IN-CLASS INHIBITOR OF DNA DAMAGE RESPONSE AGAINST TRIPLE-NEGATIVE BREAST CANCER	GÉNESE – GILEAD BtoBEAT-TNBC - Projeto 21447	GÉNESE – GILEAD	2024-01-01	Completed
UCIBIO \| i4HB - LA/P/0140/2020 (Financiamento Complementar 2021-2025)	UCIBIO \| i4HB - LA/P/0140/2020 (Financiamento Complementar 2021-2025)	UCIBIO \| i4HB - LA/P/0140/2020	2024-01-01	In Progress
Natural product-based biomimetic-coated halloysite clay nanotubes hydrogel for cutaneous wound healing	PTDC/05270/2022	NanoBioGel	2023-03-10	Completed
CLEANWATER: Combining ecological status and microbiota diversity to decipher bioindicators for emergent micropollutants in water supply systems	2022.02124.PTDC	CLEANWATER	2023-02-01	Completed
Exploiting monoterpene indole alkaloid derivatives for overcoming resistance in BRCA-deficient cancers. In silico characterization of binding modes	2022.05718.PTDC	IndoleBRCA	2023-01-01	Completed
COST ACTION CA21111: One Health drugs against parasitic vector-borne diseases in Europe and beyond OneHealthdrugs	COST 025/22	COST ACTION CA21111: OneHealthdrugs	2022-10-24	In Progress
A game-changer in Antimicrobial resistance threat:characterization of a promising antibiotic candidate from a soil isolate.	Investigação em Doenças Infecciosas	Investigação em Doenças Infecciosas	2022-10-01	Completed
Unveiling the microbiota of olive pomace for a new fermented food with potential synbiotic action	EXPL/SAU-NUT/0370/2021	FERMOPSY	2022-01-10	Completed
Can coffee by-products decrease the risk of metabolic syndrome? A comprehensive approach to reduce waste and valorize health benefits	PTDC/SAU-NUT/2165/2021	COBY4HEALTH	2022-01-01	Completed
Exploring the bacteriocinome of human Enterococcus faecium – paving avenues towards multidrug-resistant infections targeted therapies	EXPL/SAU-INF/0261/2021	BENEFIT	2022-01-01	Completed
A NEW ANTICANCER DRUG CANDIDATE AGAINST BREAST AND OVARIAN CANCER BY TARGETING HOMOLOGOUS RECOMBINATION DNA REPAIR	BBIT20	BBIT20	2021-11-30	Completed
One Health in practice: studying the persistence of Enterobacteriaceae with zoonotic potential in poultry farms using ITM or OTM feed to prevent their transfer into the human food chain	IJUP2021-SOJA DE PORTUGAL-14	IJUP2021-SOJA DE PORTUGAL-14	2021-08-01	Completed
Cancer Research on Therapy Resistance: From Basic Mechanisms to Novel Targets	NORTE-01-0145-FEDER-000051	Cancer Research on Therapy Resistance: From Basic Mechanisms to Novel Targets	2021-03-01	Completed

Records 1 to 20 from 163

2 3 4 5 6

Recommend this page Top

Copyright 1996-2025 © Faculdade de Farmácia da Universidade do Porto I Terms and Conditions I Acessibility I Index A-Z I Guest Book
Page created on: 2025-06-16 at 02:15:35 | Acceptable Use Policy | Data Protection Policy | Complaint Portal